Loading company details...
Beta
Latest Form 4 (Aug 7, 2026): Lloyd Klickstein (Chief Medical Officer): Grant/Award of 18,300 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Lloyd Klickstein, Chief Medical Officer | Grant/Award | 18,300 | n/a |
| Jun 23, 2026 | Chen Schor, President & CEO | Grant/Award | 55,000 | n/a |
| Jun 23, 2026 | Blake Aftab, Chief Scientific Officer | Grant/Award | 55,000 | n/a |
| Jun 23, 2026 | Steve Dubin | Grant/Award | 4,200 | n/a |
| Jun 23, 2026 | Jeffrey Chodakewitz | Grant/Award | 4,200 | n/a |
| Jun 23, 2026 | Michael Grissinger | Grant/Award | 4,200 | n/a |
| Jun 23, 2026 | Andrew Sinclair | Grant/Award | 4,200 | n/a |
| Jun 23, 2026 | Katie Peng | Grant/Award | 4,200 | n/a |
| Jun 23, 2026 | Lloyd Klickstein | Grant/Award | 4,200 | n/a |
| Apr 29, 2026 | RA CAPITAL MANAGEMENT, L.P. | Other (see footnotes) | 250,000 | n/a |